X
Request a Demo

May 24, 2024

Astrata Named Winner of KLAS Research K2 Peak Award

May 24, 2024, PITTSBURGH, PA  Astrata, Inc in partnership with AmeriHealth Caritas, Prospect Medical Holdings, Inc., and ELLKAY have won a KLAS Research K2 Peak Award for their successful payer-provider collaboration. The team was selected out of 16 other Points of Light collaborations by the participants at KLAS’ K2 Summit.

“I congratulate the newest winners of the K2 Peak Award for outstanding payer-provider collaboration. This recognition serves as a testament to the remarkable possibilities that emerge when healthcare executives and their partners unite with a shared goal of enhancing healthcare outcomes while driving efficiency. We are honored to acknowledge their accomplishments and anticipate that their pioneering efforts will motivate others to emulate their success.” – Adam Gale, CEO of KLAS.

About KLAS

KLAS is a research and insights firm on a global mission to improve healthcare. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software and services to deliver timely reports and performance data that represent provider and payer voices and act as catalysts for improving vendor performance. The KLAS research team publishes reports covering the most pressing questions facing healthcare technology today, including emerging technology insights, that provide early insights on the future of healthcare technology solutions. KLAS also fosters measurement and collaboration between healthcare providers and payers and best practice adoption. Learn more at KLASresearch.com.

About Astrata

Astrata is a digital quality company, offering a suite of products and services for health plans and value-driven providers who are moving from paper-based clinical quality measures to digital clinical quality measures, as required by NCQA and CMS. Astrata’s products make it possible to better measure and improve healthcare quality, a foundation for moving to value-based care. Astrata’s value propositions include dramatic efficiency gains, higher clinical quality rates, and increased quality bonus payments.